Skip to main content
Pharma Mar S.A. logo

Pharma Mar S.A. — Investor Relations & Filings

Ticker · PHM ISIN · ES0169501022 LEI · 959800QWKZ45ZQC2AV58 MC Manufacturing
Filings indexed 351 across all filing types
Latest filing 2024-06-24 Transaction in Own Shar…
Country ES Spain
Listing MC PHM

About Pharma Mar S.A.

https://pharmamar.com/en/

Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.

Recent filings

Filing Released Lang Actions
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 17 de junio y el 21 de junio de 2024.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'Comisión Nacional del Mercado de Valores' (Spanish Securities Market Commission) dated June 24, 2024. The subject is 'Programas de recompra de acciones, estabilización y autocartera' (Share repurchase programs, stabilization, and treasury stock) and it details specific 'Compra' (Buy) transactions of the company's own shares ('autocartera') executed between June 17 and June 21, 2024. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The code for this is POS.
2024-06-24 Spanish
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 10 de junio y el 14 de junio de 2024.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'Comisión Nacional del Mercado de Valores' (Spanish Securities Market Commission) dated June 17, 2024. The title is 'COMUNICACIÓN DE OTRA INFORMACIÓN RELEVANTE' (Communication of Other Relevant Information) concerning 'Programas de recompra de acciones, estabilización y autocartera' (Share repurchase programs, stabilization, and treasury stock). The text details specific 'Compra' (Buy) operations of the company's own shares ('autocartera') conducted between June 10 and June 14, 2024, including transaction dates, volume, and price. This directly corresponds to the definition of reporting the company's activity regarding buying back its own shares. Reviewing the definitions: - 10-K/IR: Not a full annual or interim financial report. - ER: Not an earnings release. - DIRS: This is about the company's own transactions, not director's personal dealings. - POS (Transaction in Own Shares): This definition perfectly matches the content: 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Therefore, the classification is POS.
2024-06-17 Spanish
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 3 de junio y el 7 de junio de 2024.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'Comisión Nacional del Mercado de Valores' (Spanish Securities Market Commission) dated June 10, 2024. The title is 'COMUNICACIÓN DE OTRA INFORMACIÓN RELEVANTE' (Communication of Other Relevant Information) and the subject is 'Programas de recompra de acciones, estabilización y autocartera' (Share repurchase programs, stabilization, and treasury stock). It details specific 'Compra' (Buy) operations conducted by Pharma Mar, S.A. for its own shares during the period June 3 to June 7, 2024. This activity—the reporting of transactions involving the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general earnings release (ER), a full annual report (10-K), or a management discussion (MDA).
2024-06-10 Spanish
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 27 de mayo y el 31 de mayo de 2024.
Regulatory Filings Classification · 99% confidence The document is a formal communication addressed to the 'Comisión Nacional del Mercado de Valores' (CNMV), the Spanish securities market regulator. The title is 'COMUNICACIÓN DE OTRA INFORMACIÓN RELEVANTE' (Communication of Other Relevant Information). The content explicitly discusses the status of a previously announced share repurchase program ('Programa de Recompra') for the period of May 27 to May 31, 2024, stating that no operations were carried out under that program during that week. This type of regular disclosure regarding insider transactions, share buybacks, or stabilization activities, especially when reported weekly or periodically to the regulator, falls under the category of transactions in own shares or general regulatory disclosure. Since the document specifically details the activity (or lack thereof) under a share repurchase program, the most precise classification is 'Transaction in Own Shares' (POS). It is a specific regulatory disclosure, not a general announcement of a report (RPA/RNS).
2024-06-03 Spanish
La Sociedad informa sobre el pago del dividendo
Notice of Dividend Amount Classification · 99% confidence The document is a formal communication addressed to the 'Comisión Nacional del Mercado de Valores' (CNMV, the Spanish securities market regulator) under the heading 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The core content explicitly details the execution of a dividend payment approved at the recent Annual General Meeting (AGM). It specifies the gross amount (€0.65 per share), the net amount, and crucial dates such as the last trading date, ex-date, record date, and payment date (June 14, 2024). This content directly relates to the announcement of a dividend amount and payment details, matching the definition for 'Notice of Dividend Amount' (DIV). It is not a full report (10-K, IR), a transcript (CT), or a general regulatory filing (RNS), as it concerns a specific financial action.
2024-05-29 Spanish
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 20 de mayo y el 24 de mayo de 2024.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the Spanish National Securities Market Commission ("Comisión Nacional del Mercado de Valores") dated May 27, 2024. The subject is "Programas de recompra de acciones, estabilización y autocartera" (Share repurchase programs, stabilization, and treasury stock) and it details transactions conducted under a previously announced Share Repurchase Program between May 20 and May 24, 2024. This explicitly reports on the company buying back its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). It is not a general insider trade report (DIRS), nor is it a general financing update (CAP), but a specific report on treasury stock operations.
2024-05-27 Spanish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.